AN OPEN-LABEL, PHASE 2 STUDY TO EVALUATE THE ORAL COMBINATION OF IXAZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

Saved in:
Bibliographic Details
Published inHAEMATOLOGICA Vol. 102; p. 111
Main Authors Dimopoulos, MA, Grosicki, S, Jedrzejczak, W, Nahi, H, Gruber, A, Hansson, M, Byrne, C, Labotka, R, Teng, Z, Yang, H, Grzasko, N, Kumar, S
Format Conference Proceeding
LanguageEnglish
Published 2017
Subjects
Medicin och hälsovetenskap
Online AccessGet full text

Cover

More Information
ISSN:0390-6078